Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Symrise AG is a Germany-based company. The Company is engaged as a supplier of fragrances, flavorings, cosmetic active ingredients and raw materials, functional ingredients and product solutions for food production based on natural base materials. The Company operates through two segments: Taste, Nutrition & Health and Scent & Care segment. The Taste, Nutrition & Health segment includes the Food & Beverage and Pet Food divisions as well as the two smaller units Aqua Feed and Probi. It uses scientific research to offer customers and partners solutions in the areas of taste, nutrition and health that are sustainable and based on natural ingredients. The Company develops specific active solutions for the desired health benefits. The Scent & Care segment includes the Fragrance, Cosmetic Ingredients and Aroma Molecules divisions. The Fragrance division combine aromatic raw materials like aroma chemicals and essential oils to make complex fragrances (perfume oils).

  • Revenue in EUR (TTM)4.88bn
  • Net income in EUR392.39m
  • Incorporated2006
  • Employees12.54k
  • Location
    Symrise AGMuehlenfeldstrasse 1HOLZMINDEN 37603GermanyDEU
  • Phone+49 5531900
  • Fax+49 5 531901617
  • Websitehttps://www.symrise.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Wacker Chemie AG5.86bn124.40m3.91bn16.56k29.910.83336.700.66632.502.50118.0389.880.66123.206.45357,968.001.635.162.026.2914.7221.652.466.601.51--0.280466.04-22.015.16-74.934.979.373.71
Brenntag SE16.19bn544.50m8.16bn17.70k15.381.879.220.50393.673.67109.0730.281.498.206.72914,269.605.106.407.309.0224.6623.033.414.021.0410.120.434837.40-13.456.03-19.389.1812.4711.84
Evonik Industries AG15.16bn228.00m8.35bn33.58k37.310.9266.450.55070.48030.480332.0219.350.75144.228.64453,859.801.212.011.542.4225.2525.471.612.900.73719.950.3168130.72-17.422.85-186.27---3.510.3454
Symrise AG4.88bn392.39m14.86bn12.54k37.893.9521.063.042.812.8134.9226.900.61862.404.94392,584.405.024.995.805.9537.1037.938.118.131.647.170.40143.832.428.4421.594.043.444.10
BASF SE65.27bn498.00m37.83bn112.08k75.951.096.540.57950.5580.55873.1338.920.8063.315.76582,850.400.80511.681.042.1925.5424.960.99892.001.03--0.3823247.02-21.102.73135.89-43.316.741.22
Data as of Nov 13 2024. Currency figures normalised to Symrise AG's reporting currency: Euro EUR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.